Cargando…
Real-World Evidence in the Management of Diabetic Macular Edema with Intravitreal Anti-VEGFs in Asia: A Systematic Literature Review
PURPOSE: To evaluate the visual outcomes and safety profile of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy in the treatment of diabetic macular edema (DME) in real-world studies in Asian countries. METHODS: A systematic review of electronic literature databases (Embase,...
Autores principales: | Yuen, Yew Sen, Tan, Gavin Siew Wei, Gan, Nicola Yi’An, Too, Issac Horng Khit, Mothe, Raj Kumar, Basa, Pradeep, Shaikh, Javed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579008/ https://www.ncbi.nlm.nih.gov/pubmed/36274678 http://dx.doi.org/10.2147/OPTH.S378392 |
Ejemplares similares
-
Understanding patient preferences in anti-VEGF treatment options for age-related macular degeneration
por: Ozdemir, Semra, et al.
Publicado: (2022) -
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
por: Koc, Hakan, et al.
Publicado: (2023) -
Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
por: Garoon, Robert B., et al.
Publicado: (2016) -
Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion
por: Bae, Young Hwan, et al.
Publicado: (2021) -
Synergistic Effect of Combined Sub-Tenon Triamcinolone and Intravitreal Anti-VEGF Therapy for Uveitic Macular Edema
por: Lin, Dan, et al.
Publicado: (2022)